EcoDrugPlus

Ensembl ID : ML032222a
Gene Symbol: -
External references: -
463 Possible Orthologues:

Ensembl ID : ML032332a
Gene Symbol: -
External references: -
73 Possible Orthologues:

Ensembl ID : ML03248a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML032518a
Gene Symbol: -
External references: -
279 Possible Orthologues:

Ensembl ID : ML03299a
Gene Symbol: -
External references: -
203 Possible Orthologues:

Ensembl ID : ML03311a
Gene Symbol: -
External references: -
78 Possible Orthologues:

Ensembl ID : ML03312a
Gene Symbol: -
External references: -
128 Possible Orthologues:

Ensembl ID : ML03315a
Gene Symbol: -
External references: -
123 Possible Orthologues:

Ensembl ID : ML033233a
Gene Symbol: -
External references: -
74 Possible Orthologues:

Ensembl ID : ML033411a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML033412a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).